C12N15/113 - page 39 - CPC Classification Index

#11401

20110257247

2011-10-20

Method of Treating Neurodegenerative Disease

#11402

20110257246

2011-10-20

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

#11403

20110257244

2011-10-20

CHEMICALLY MODIFIED OLIGONUCLEOTIDES AND SMALL MOLECULES FOR USE IN REDUCING MICRO RNA ACTIVITY LEVELS AND USES THEREOF

#11404

20110256156

2011-10-20

Transferrin/transferrin receptor-mediated siRNA delivery

#11405

20110256150

2011-10-20

Modulation of axon degeneration

#11406

20110256090

2011-10-20

Method for Identifying Genes Involved in Trail-Induced Apoptosis and Therapeutic Applications Thereof

#11407

20110251261

2011-10-13

Compositions and methods for inhibition of nucleic acids function

#11408

20110251260

2011-10-13

NOVEL siRNAS AND METHODS OF USE THEREOF

#11409

20110251257

2011-10-13

METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE

#11410

20110251256

2011-10-13

Use of TRIM72 as a target for muscle and heart enhancer

#11411

20110251150

2011-10-13

Targeting MicroRNAs For The Treatment Of Liver Cancer

#11412

20110250608

2011-10-13

USE OF ULTRACONSERVED RNA IN DETECTION AND TREATMENT OF CANCER

#11413

20110250261

2011-10-13

Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription

#11414

20110250228

2011-10-13

Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin

#11415

20110250204

2011-10-13

Methods and compositions for diagnosing and treating diseases

#11416

20110245481

2011-10-06

Method for inhibiting function of micro-RNA

#11417

20110245325

2011-10-06

Pharmaceutical composition for treatment of cancer and asthma

#11418

20110245320

2011-10-06

Nuclease resistant double-stranded ribonucleic acid

#11419

20110245318

2011-10-06

RNA sequence-specific mediators of RNA interference

#11420

20110244568

2011-10-06

RNA sequence-specific mediators of RNA interference

#11421

20110244562

2011-10-06

RNA interference suppression of neurodegenerative diseases and methods of use thereof

#11422

20110244561

2011-10-06

SiRNA-mediated gene silencing

#11423

20110244509

2011-10-06

ApoIII and the treatment and diagnosis of diabetes

#11424

20110244446

2011-10-06

RNA sequence-specific mediators of RNA interference

#11425

20110244059

2011-10-06

INHIBITING OBESITY PROGRESSION BY INHIBITING ADIPOCYTE DIFFERENTIATION WITH A PRE-ADIPOCYTE AUTOPHAGY INHIBITOR

#11426

20110244024

2011-10-06

Microrna compositions and methods for the treatment of myelogenous leukemia

#11427

20110243968

2011-10-06

Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer

#11428

20110243957

2011-10-06

MATERIALS AND METHODS FOR PREVENTING OR TREATING NEURODEGENERATIVE CONDITIONS ASSOCIATED WITH ABETA PEPTIDE ACCUMULATION

#11429

20110243937

2011-10-06

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

#11430

20110243927

2011-10-06

METHODS OF INHIBITING TUMOR GROWTH USING BETA 5 INTEGRIN ANTAGONISTS

#11431

20110243899

2011-10-06

Wnt Signaling Inhibitor Comprising Insulin-Like Growth Factor-Binding Protein

#11432

20110243841

2011-10-06

Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells

#11433

20110239312

2011-09-29

Methods of diagnosing and treating motor neuron diseases

#11434

20110237652

2011-09-29

Detection and destruction of cancer cells using programmed genetic vectors

#11435

20110237651

2011-09-29

Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO

#11436

20110237648

2011-09-29

RNA interference in skin indications

#11437

20110237647

2011-09-29

Inhibitory RNA for modulating the molecular function of ZFAT gene

#11438

20110237643

2011-09-29

Identification of a novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity

#11439

20110237522

2011-09-29

Neutral nanotransporters

#11440

20110237518

2011-09-29

Method for treating or preventing bladder cancer using the DEPDC1 polypeptide

#11441

20110236972

2011-09-29

NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF

#11442

20110236403

2011-09-29

Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy

#11443

20110236397

2011-09-29

LIMITED PROTEOLYSIS OF CD2AP AND PROGRESSION OF RENAL DISEASE

#11444

20110236370

2011-09-29

Genetic Alterations on Chromosomes 21q, 6q and 15q and Methods of Use Thereof for the Diagnosis and Treatment of Type I Diabetes

#11445

20110230544

2011-09-22

Modulation of C-reactive protein expression

#11446

20110230543

2011-09-22

Oligoribonucleotide inhibitors of Nrf2 and methods of use thereof for treatment of cancer

#11447

20110230410

2011-09-22

Low density lipoprotein receptor-mediated siRNA delivery

#11448

20110229966

2011-09-22

Nanoparticle-based gene delivery systems

#11449

20110229558

2011-09-22

AGENT FOR TREATING MYELOFIBROSIS

#11450

20110229557

2011-09-22

Double-stranded oligonucleotide compound for down-regulating the expression of CASP2 gene

#11451

20110229531

2011-09-22

ANTI-PROTOZOA COMPOUNDS

#11452

20110229498

2011-09-22

COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE

#11453

20110229484

2011-09-22

Host cell kinases as targets for antiviral therapies against HCV infection

#11454

20110229468

2011-09-22

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

#11455

20110229467

2011-09-22

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

#11456

20110225683

2011-09-15

Importation of a ribozyme into vegetable mitochondria by a pseudo-tRNA that can be aminoacylated by valine

#11457

20110224285

2011-09-15

Oligomeric compounds for the modulation of HIF-1α expression

#11458

20110224284

2011-09-15

PUTATIVE TUMOR SUPPRESSOR MICRORNA-101 MODULATES THE CANCER EPIGENOME BY REPRESSING THE POLYCOMB GROUP PROTEIN EZH2

#11459

20110224281

2011-09-15

RNA ANTAGONISTS TARGETING HSP70-2

#11460

20110224277

2011-09-15

Oligomeric compounds and compositions for use in modulation of small non-coding RNAS

#11461

20110224149

2011-09-15

Polynucleotides for use in treating and diagnosing cancers

#11462

20110223656

2011-09-15

MicroRNAs and Uses Thereof

#11463

20110223217

2011-09-15

Block copolymers and uses thereof

#11464

20110223171

2011-09-15

Methods and Compositions for the Diagnosis and Treatment of Cyclin A-1 Associated Conditions

#11465

20110223162

2011-09-15

Targeting PAX2 for the treatment of breast cancer

#11466

20110223161

2011-09-15

Targeting PAX2 for the treatment of breast cancer

#11467

20110223152

2011-09-15

Use of inhibitors of leukotriene B4 receptor BLT2 for treating human cancers

#11468

20110218232

2011-09-08

Inhibitors of MRP4 and agents stimulating MRP4 activity for the treatment of cardiac disorders

#11469

20110217367

2011-09-08

Means for inhibiting the expression of Orc-1

#11470

20110217326

2011-09-08

Method for diagnosing and/or treating tumor

#11471

20110217299

2011-09-08

Targeting PAX2 for the treatment of breast cancer

#11472

20110217267

2011-09-08

Gene therapy vectors and cytosine deaminases

#11473

20110213010

2011-09-01

Methods and compositions for the treatment of Huntington'S disease

#11474

20110213008

2011-09-01

Pharmaceutical containing HIF-1 alpha and HIF-2 alpha expression inhibitor

#11475

20110213007

2011-09-01

MicroRNAs and uses thereof

#11476

20110212520

2011-09-01

RNA interference suppression of neurodegenerative diseases and methods of use thereof

#11477

20110212089

2011-09-01

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

#11478

20110212081

2011-09-01

KRÜPPEL-LIKE FACTORS AND FAT REGULATION

#11479

20110207917

2011-08-25

SAM-6 VARIANTS, TARGET AND METHODS OF USE

#11480

20110207799

2011-08-25

Compositions for targeted delivery of siRNA

#11481

20110207795

2011-08-25

SMAD7 INHIBITOR COMPOSITIONS AND USES THEREOF

#11482

20110207224

2011-08-25

In vivo production of small interfering RNAs that mediate gene silencing

#11483

20110207217

2011-08-25

Modulation of gene expression by oligomers targeted to chromosomal DNA

#11484

20110206703

2011-08-25

Gene signature for predicting prognosis of patients with solid tumors

#11485

20110206689

2011-08-25

Molecular Determinants Associated With Prostate Cancer And Methods Of Use Thereof

#11486

20110206685

2011-08-25

SCREENING ASSAYS FOR INHIBITORS OF A STAPHYLOCOCCUS AUREUS SIDEROPHORE

#11487

20110206666

2011-08-25

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

#11488

20110206665

2011-08-25

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

#11489

20110201798

2011-08-18

Therapeutic compositions

#11490

20110201677

2011-08-18

PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME

#11491

20110200620

2011-08-18

B7-H1 and methods of diagnosis, prognosis, and treatment of cancer

#11492

20110196019

2011-08-11

Treatment of cancer by inhibition of IGFBPs and clusterin

#11493

20110195411

2011-08-11

ARL-1 specific antibodies and uses thereof

#11494

20110195127

2011-08-11

Compositions and methods for silencing apolipoprotein B

#11495

20110190445

2011-08-04

Inhibition of HRP-3 using modified oligonucleotides

#11496

20110190382

2011-08-04

Treatment of cancer by inhibition of IGFBPs and clusterin

#11497

20110190381

2011-08-04

RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma

#11498

20110190377

2011-08-04

Method for producing a cell and/or tissue and/or disease phase specific medicament

#11499

20110190376

2011-08-04

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA

#11500

20110190372

2011-08-04

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISORDERS

#11501

20110190370

2011-08-04

Modulation of HIF1α and HIF2α expression

#11502

20110190222

2011-08-04

Selective inhibition of polyglutamine protein expression

#11503

20110189776

2011-08-04

Prokaryotic RNAi-like system and methods of use

#11504

20110189300

2011-08-04

siRNA SILENCING OF APOLIPOPROTEIN B

#11505

20110189193

2011-08-04

CELL LINES AND HOST NUCLEIC ACID SEQUENCES RELATED TO INFECTIOUS DISEASE

#11506

20110189137

2011-08-04

METHOD FOR GENERATION AND REGULATION OF IPS CELLS AND COMPOSITIONS THEREOF

#11507

20110184050

2011-07-28

Methods and means for treating DNA repeat instability associated genetic disorders

#11508

20110184048

2011-07-28

Uses and compositions comprising miRNAs

#11509

20110184047

2011-07-28

RNAi modulation of SCAP and therapeutic uses thereof

#11510

20110184046

2011-07-28

Compositions And Methods For Inhibiting Expression Of GSK-3 Genes

#11511

20110184043

2011-07-28

Inhibition of angiogenesis

#11512

20110183931

2011-07-28

Potent LNA oligonucleotides for the inhibition of HIF-1A expression

#11513

20110183912

2011-07-28

AGENT FOR PROMOTING NEURONAL DIFFERENTIATION AND METHOD THEREFOR

#11514

20110183417

2011-07-28

Polyamides for nucleic acid delivery

#11515

20110182867

2011-07-28

Modulation of BCL11A for treatment of hemoglobinopathies

#11516

20110179501

2011-07-21

Methods for reverting methylation by targeting methyltransferases

#11517

20110178162

2011-07-21

Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy

#11518

20110178159

2011-07-21

INHIBITORY RNAS THAT REGULATE HEMATOPOIETIC CELLS

#11519

20110178157

2011-07-21

Modulation of HSP47 expression

#11520

20110178155

2011-07-21

Silencing of CSN5 gene expression using interfering RNA

#11521

20110177967

2011-07-21

Methods and compositions using splicing regulatory proteins involved in tumor suppression

#11522

20110177160

2011-07-21

Amino acid lipids and uses thereof

#11523

20110177101

2011-07-21

TARGETING PAX2 FOR THE INDUCTION OF DEFB1-MEDIATED TUMOR IMMUNITY AND CANCER THERAPY

#11524

20110177100

2011-07-21

Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy

#11525

20110177097

2011-07-21

METHODS FOR MODULATING EXPRESSION OF CREB

#11526

20110177075

2011-07-21

TARGETING PAX2 FOR THE INDUCTION OF DEFB1-MEDIATED TUMOR IMMUNITY AND CANCER THERAPY

#11527

20110172295

2011-07-14

METHODS AND COMPOSITIONS FOR THE REGULATION OF microRNA PROCESSING

#11528

20110172293

2011-07-14

Methods and Compositions for Modulating Angiogenesis

#11529

20110172291

2011-07-14

RNA interference for the treatment of gain-of-function disorders

#11530

20110172162

2011-07-14

Chemotherapy involving antisense oligonucleotides for preventing and/or treating pulmonary fibrosis

#11531

20110172120

2011-07-14

Compositions and Systems for the Regulation of Genes

#11532

20110171727

2011-07-14

COMPOSITIONS AND METHODS FOR ACTIVATING GENES OF INTEREST

#11533

20110171221

2011-07-14

COMPOSITIONS AND METHODS FOR THE TREATMENT OF A NEOPLASIA

#11534

20110171184

2011-07-14

Method for Introducing a Pna Molecule Conjugated to a Positively Charged Peptide into the Cytosol and/or the Nucleus by Photochemical Internalisation (Pci)

#11535

20110171176

2011-07-14

Complement antagonists and uses thereof

#11536

20110166212

2011-07-07

Gene expression and pain

#11537

20110166204

2011-07-07

Oligonucleotides of human endogenous retrovirus 9 (ERV-9) long terminal repeat (LTR) and methods of use

#11538

20110166201

2011-07-07

miRNAs as therapeutic targets in cancer

#11539

20110166199

2011-07-07

RNAi compound targeted to thrombospondin-1 and applications thereof

#11540

20110166058

2011-07-07

Organic compositions to treat HSF1-related diseases

#11541

20110166041

2011-07-07

Diagnosis/Therapeutic Strategy For Gynecological Cancer by Utilizing Micro-RNA as Biomarker

#11542

20110165669

2011-07-07

Anti-MicroRNA oligonucleotide molecules

#11543

20110165123

2011-07-07

5′ triphosphate oligonucleotide with blunt end and uses thereof

#11544

20110160707

2011-06-30

Compositions, devices and methods for treatment of Huntington's disease through intracranial delivery of sirna

#11545

20110160292

2011-06-30

Regulation of Integrin Surface Expression

#11546

20110160287

2011-06-30

Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof

#11547

20110160283

2011-06-30

Modulation of CD40 expression

#11548

20110160281

2011-06-30

RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)

#11549

20110160280

2011-06-30

CANCER-RELATED GENES, CDCA5, EPHA7, STK31 AND WDHD1

#11550

20110159587

2011-06-30

Chimeric Molecules to Modulate Gene Expression

#11551

20110152357

2011-06-23

Micro-RNA-Based Compositions and Methods for the Diagnosis, Prognosis and Treatment of Multiple Myeloma

#11552

20110152354

2011-06-23

Bispecific oligonucleotide for the treatment of CNS malignancies

#11553

20110152351

2011-06-23

Modulation of SMRT expression

#11554

20110152350

2011-06-23

Compositions and methods for inhibiting expression of XBP-1 gene

#11555

20110152347

2011-06-23

Methods and compositions for controlling efficacy of RNA silencing

#11556

20110152346

2011-06-23

Use of Oligonucleotides with Modified Bases in Hybridization of Nucleic Acids

#11557

20110152345

2011-06-23

EBI3, DLX5, NPTX1 AND CDKN3 FOR TARGET GENES OF LUNG CANCER THERAPY AND DIAGNOSIS

#11558

20110152215

2011-06-23

RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES

#11559

20110152213

2011-06-23

Riboswitches, methods for their use, and compositions for use with riboswitches

#11560

20110151558

2011-06-23

METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS

#11561

20110151471

2011-06-23

RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES

#11562

20110150897

2011-06-23

INFLUENZA TARGETS

#11563

20110150876

2011-06-23

Prognosis and treatment of breast cancer

#11564

20110150854

2011-06-23

RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES

#11565

20110144185

2011-06-16

RNA antagonists targeting Hsp27

#11566

20110143435

2011-06-16

Polymeric carrier

#11567

20110143434

2011-06-16

Diblock copolymers and polynucleotide complexes thereof for delivery into cells

#11568

20110142917

2011-06-16

Compositions and methods for treatment of ear disorders

#11569

20110142913

2011-06-16

Composition and method for treating atherosclerosis, method for determining if a subject has atherosclerosis and method of screening an anti-atherosclerotic drug

#11570

20110142820

2011-06-16

Targets for regulation of angiogenesis

#11571

20110142815

2011-06-16

Compounds, composition, methods, targets for cancer therapy

#11572

20110136891

2011-06-09

Nucleic acid molecules and collections thereof, their application and Identification

#11573

20110136890

2011-06-09

Treatment of fibrotic conditions

#11574

20110135710

2011-06-09

Methods and compositions for the inhibition of gene expression

#11575

20110135646

2011-06-09

Genes of an otitis media isolate of nontypeable

#11576

20110135632

2011-06-09

Methods for the modulation of angiogenesis

#11577

20110135613

2011-06-09

METHODS FOR TREATING APOLIPOPROTEIN E4-ASSOCIATED DISORDERS

#11578

20110131668

2011-06-02

IMPROVED GENE SILENCING METHODS

#11579

20110130443

2011-06-02

Compositions and methods for inhibiting expression of factor V

#11580

20110130442

2011-06-02

NUCLEIC ACID CAPABLE OF CONTROLLING DEGRANULATION OF MAST CELL

#11581

20110130341

2011-06-02

Method and kit for detection of cancer, and therapeutic agent for cancer

#11582

20110126321

2011-05-26

Recombinant DNA for gene suppression

#11583

20110124591

2011-05-26

Compounds and methods for modulating protein expression

#11584

20110124108

2011-05-26

EPIGENETIC ENGINEERING

#11585

20110124099

2011-05-26

IKKALPHA AND IKKBETA SPECIFIC INHIBITORS

#11586

20110123538

2011-05-26

COMPOSITION COMPRISING EXPRESSION OR ACTIVITY INHIBITORS OF NINJURIN 1 FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASE

#11587

20110123521

2011-05-26

Methods for modulating expression of RBP4

#11588

20110118456

2011-05-19

Interfering RNA molecules

#11589

20110118339

2011-05-19

CHEMICALLY MODIFIED OLIGONUCLEOTIDES AND USES THEREOF

#11590

20110118337

2011-05-19

Method of Using Compositions Comprising MIR-192 and/or MIR-215 for the Treatment of Cancer

#11591

20110118334

2011-05-19

Antisense antiviral compound and method for treating influenza viral infection

#11592

20110118187

2011-05-19

REVERSIBLE PLATELET INHIBITION

#11593

20110117646

2011-05-19

Antisense modulation of C-reactive protein expression

#11594

20110117567

2011-05-19

Micro-RNA Associated With Rheumatoid Arthritis

#11595

20110117181

2011-05-19

TREATING HEPATITIS C VIRUS INFECTION WITH OVER-EXPRESSION OF MICRORNA-196

#11596

20110117102

2011-05-19

Therapeutic uses of inhibitors of RTP801

#11597

20110112284

2011-05-12

Methods for modulating IKKα activity

#11598

20110112283

2011-05-12

RNA interference mediating small RNA molecules

#11599

20110112176

2011-05-12

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF KIF10 GENES

#11600

20110112170

2011-05-12

Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity

#11601

20110112169

2011-05-12

RNAi-BASED THERAPEUTICS FOR ALLERGIC RHINITIS AND ASTHMA

#11602

20110111983

2011-05-12

siRNA targeting spleen tyrosine kinase

#11603

20110111496

2011-05-12

BACTERIA-MEDIATED GENE MODULATION VIA microRNA MACHINERY

#11604

20110111491

2011-05-12

RNA interference suppresion of neurodegenerative diseases and methods of use thereof

#11605

20110111481

2011-05-12

ENABLING THE USE OF LONG dsRNA FOR GENE TARGETING IN MAMMALIAN AND OTHER SELECTED ANIMAL CELLS

#11606

20110111398

2011-05-12

NUCLEIC ACID PROBE-BASED DIAGNOSTIC ASSAYS TARGETING SSRA GENES OF PROKARYOTIC AND EUKARYOTIC ORGANISMS

#11607

20110111041

2011-05-12

Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells

#11608

20110110960

2011-05-12

Mannose-6-phosphate receptor mediated gene transfer into muscle cells

#11609

20110107468

2011-05-05

Plant regulatory elements from a metallothionein-like gene and uses thereof

#11610

20110105740

2011-05-05

SOLUBLE TNF RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE

#11611

20110105592

2011-05-05

Anti-sense microrna expression vectors

#11612

20110105591

2011-05-05

siRNA compounds for inhibiting NRF2

#11613

20110105590

2011-05-05

Compositions and methods for inhibiting expression of anti-apoptotic genes

#11614

20110105586

2011-05-05

Compositions and their uses directed to gemin genes

#11615

20110105585

2011-05-05

METHODS FOR DIAGNOSING AND TREATING SQUAMOUS CELL CARCINOMA UTILIZING miRNA-205 AND INHIBITORS THEREOF

#11616

20110105584

2011-05-05

RTP80IL SIRNA COMPOUNDS AND METHODS OF USE THEREOF

#11617

20110105583

2011-05-05

Methods of using MIR34 as a biomarker for TP53 functional status

#11618

20110105422

2011-05-05

USE OF G-RICH OLIGONUCLEOTIDES FOR TREATING NEOPLASTIC DISEASES

#11619

20110105363

2011-05-05

siRNA targeting TNFa

#11620

20110104255

2011-05-05

THERAPEUTIC AGENT FOR FIBROID LUNG

#11621

20110104050

2011-05-05

Compositions and methods for identifying and targeting cancer cells of alimentary canal origin

#11622

20110098460

2011-04-28

siRNA useful to supress expression of EIF-5A1

#11623

20110098343

2011-04-28

Antisense formulation

#11624

20110098340

2011-04-28

ANTISENSE MODULATION OF BCL2-ASSOCIATED X PROTEIN EXPRESSION

#11625

20110098339

2011-04-28

C2ORF18 AS TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS

#11626

20110098338

2011-04-28

RNA interference for the treatment of heart failure

#11627

20110097338

2011-04-28

Use of Substances for Sensitization of Tumor Cells to Radiation and/or Chemotherapy

#11628

20110097335

2011-04-28

ABC TRANSPORTER PROTEIN EXPRESSION INHIBITOR

#11629

20110097329

2011-04-28

COMPOSITIONS AND METHODS FOR TREATING CANCER AND MODULATING STRESS GRANULE FORMATION

#11630

20110097261

2011-04-28

AMIGO-2-INHIBITORS FOR TREATING, DIAGNOSING OR DETECTING CANCER

#11631

20110092575

2011-04-21

SIRNA OF HUMAN OSTEOPONTIN

#11632

20110092573

2011-04-21

Modification of MYD88 splicing using modified oligonucleotides

#11633

20110092570

2011-04-21

Oligomeric compounds comprising tricyclic nucelosides and methods for their use

#11634

20110092565

2011-04-21

METHOD OF TREATING NEURODEGENERATIVE DISEASE

#11635

20110092438

2011-04-21

Composition for external application comprising transcription factor decoy as active ingredient

#11636

20110091523

2011-04-21

Cochleate compositions directed against expression of proteins

#11637

20110091421

2011-04-21

Methods of novel therapeutic candidate identification through gene expression analysis in vascular-related diseases

#11638

20110086902

2011-04-14

Compounds for the modulation of beta-catenin expression

#11639

20110086089

2011-04-14

USE OF P27KIP1 FOR THE PREVENTION AND TREATMENT OF HEART FAILURE

#11640

20110086064

2011-04-14

COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN

#11641

20110083232

2011-04-07

Maize microrna sequences

#11642

20110082185

2011-04-07

CANCER-TESTIS GENE SILENCING AGENTS AND USES THEREOF

#11643

20110081717

2011-04-07

Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer

#11644

20110077702

2011-03-31

Means and Methods for Influencing Electrical Activity of Cells

#11645

20110077288

2011-03-31

Pharmaceutical compositions for treatment of MicroRNA related diseases

#11646

20110077286

2011-03-31

Oligonucleotide duplexes comprising DNA-like and RNA-like nucleotides and uses thereof

#11647

20110077173

2011-03-31

siRNA targeting tie-2

#11648

20110076681

2011-03-31

Modified gene-silencing nucleic acid molecules and uses thereof

#11649

20110076251

2011-03-31

NOVEL THERAPEUTIC AGENTS AGAINST HEPATITIS

#11650

20110071211

2011-03-24

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

#11651

20110071209

2011-03-24

RNAi Modulation of the RHO-A Gene and Uses Thereof

#11652

20110070653

2011-03-24

Inhibitor of histone acetyltransferase, especially p300

#11653

20110070241

2011-03-24

METHODS FOR MODULATING IMMUNE RESPONSES TO AAV GENE THERAPY VECTORS

#11654

20110070234

2011-03-24

NP1 ACTIVITY REGULATING ELEMENTS USEFUL FOR THE PRODUCTION OF DRUGS FOR THE TREATMENT OR PREVENTION OF HUMAN NEURODEGENERATIVE DISEASES, RESULTING DRUGS AND USE THEREOF

#11655

20110070221

2011-03-24

mutations in melanoma

#11656

20110070162

2011-03-24

RNA interference mediating small RNA molecules

#11657

20110065908

2011-03-17

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#11658

20110065778

2011-03-17

RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)

#11659

20110065775

2011-03-17

Compounds and methods for modulating expression of SGLT2

#11660

20110065774

2011-03-17

CHEMICALLY MODIFIED OLIGONUCLEOTIDES AND USES THEREOF

#11661

20110065773

2011-03-17

RNA interference mediating small RNA molecules

#11662

20110065650

2011-03-17

Methods of inhibiting tumor cell proliferation

#11663

20110065644

2011-03-17

COMPOSITIONS COMPRISING HUMAN PCSK9 AND APOLIPOPROTEIN B SIRNA AND METHODS OF USE

#11664

20110065109

2011-03-17

RNA interference mediating small RNA molecules

#11665

20110064724

2011-03-17

Methods for identifying compounds for the treatment of type 1 diabetes

#11666

20110061120

2011-03-10

SELF-CLEAVING RIBOZYMES AND USES THEREOF

#11667

20110060032

2011-03-10

Lipid encapsulating interfering RNA

#11668

20110060030

2011-03-10

Modulation of apolipoprotein C-III expression

#11669

20110059895

2011-03-10

MODULATION OF FACTOR 9 EXPRESSION

#11670

20110059531

2011-03-10

Method for expression of small RNA molecules within a cell

#11671

20110059094

2011-03-10

ANTITUMOR EFFECTS OF INSULIN-RESPONSIVE DNA BINDING PROTEIN-1 (IRDBP-1)

#11672

20110059067

2011-03-10

MODULATION OF OLIGONUCLEOTIDE CPG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES

#11673

20110054160

2011-03-03

Therapeutic compositions

#11674

20110054159

2011-03-03

RNA interference mediating small RNA molecules

#11675

20110054012

2011-03-03

Methods and Compositions for Increasing Gene Expression

#11676

20110054011

2011-03-03

RNA Antagonist Compounds for the Modulation of FABP4/AP2

#11677

20110054009

2011-03-03

MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders

#11678

20110054008

2011-03-03

RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma

#11679

20110054007

2011-03-03

COMPOSITIONS AND METHODS TO CONTROL INSECT PESTS

#11680

20110054003

2011-03-03

Antisense oligonucleotide modulation of STAT3 expression

#11681

20110053862

2011-03-03

COMPOSITIONS COMPRISING SURVIVIN SIRNA AND METHODS OF USE THEREOF

#11682

20110053861

2011-03-03

COMPOSITIONS COMPRISING NUCLEAR FACTOR-KAPPA B (NF-KB) SIRNA AND METHODS OF USE

#11683

20110052677

2011-03-03

MODULATION OF SRPX2-MEDIATED ANGIOGENESIS

#11684

20110052669

2011-03-03

Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity

#11685

20110052502

2011-03-03

MicroRNA Signatures Associated with Human Chronic Lymphocytic Leukemia (CCL) and Uses Thereof

#11686

20110047645

2011-02-24

Compositions and Methods of Using RNA Interference for Control of Nematodes

#11687

20110046360

2011-02-24

ENA nucleic acid drugs modifying splicing in mRNA precursor

#11688

20110046209

2011-02-24

RNA-induced translational silencing and cellular apoptosis

#11689

20110046206

2011-02-24

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#11690

20110046203

2011-02-24

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

#11691

20110046200

2011-02-24

Use of antisense oligonucleotides to effect translation modulation

#11692

20110044931

2011-02-24

Multi-conjugate of siRNA and preparing method thereof

#11693

20110039914

2011-02-17

Modified RNAi polynucleotides and uses thereof

#11694

20110039912

2011-02-17

Therapeutic agent for neuroblastoma targeting ARID3b

#11695

20110039910

2011-02-17

Modulation of apolipoprotein (a) expression

#11696

20110039734

2011-02-17

siRNA targeting connective tissue growth factor (CTGF)

#11697

20110039334

2011-02-17

Chimeric oligomeric compounds for modulation of splicing

#11698

20110038853

2011-02-17

Use of Kif13A and AP-1 Inhibitors for Inhibiting Melanogenesis

#11699

20110038852

2011-02-17

ANTIVIRALS THAT TARGET TRANSPORTERS, CARRIERS, AND ION CHANNELS

#11700

20110038849

2011-02-17

INHIBITORY POLYNUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATING CANCER